Anlon Healthcare Limited Stock Price

NSEI:AHCL Community·₹8.0b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
1 Fair Values set on narratives written by author

Create Narrative

AHCL Share Price Performance

₹15.06

5.89 (64.18%)

₹15.06

5.89 (64.18%)

₹15.06

Sun, 14 Jun 26

Share Pricen/a

AHCL Community Narratives

There are no narratives available yet.

Create Narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Excellent balance sheet with questionable track record.

2 Risks

2 Rewards

View Full Analysis

Anlon Healthcare Limited Key Details

Last Reported Earnings

Mar 31, 2026

Next Reporting Earnings

n/a

: 0.54
: 38.88%
: 16.58%
: 17.1%

View Full Analysis

About AHCL

Founded: 2013
Employees: n/a
CEO: Punitkumar Rasadia
WebsiteView website: www.anlon.in

Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally. The company offers active pharmaceutical ingredients (API); nutraceutical API products; personal care ingredients; and veterinary API products. Its products are used in anti-inflammatory (NSAID), analgesic, antipyretic, antihistamine, antidepressant, antipsychotic, anticoagulant, antihypertensive, nutrition, anti-arrhythmic, anti-hyper parathyroid, antiplatelet, ant diabetic, gastroesophageal reflux disease (GERD), and anti-rheumatic therapeutics areas. The company was incorporated in 2013 and is based in Rajkot, India.